SUMMARY A new variant of G6PD associated with chronic non-spherocytic haemolytic anaemia (CNSHA) in an Irish male is described. This variant is unique in that it has a normal electrophoretic mobility, Michaelis constant for G6P and NADP, and a normal pH optimum, together with a marked increase in utilisation of the substrate 2 deoxy glucose-6-phosphate. It is also relatively heat stable when compared with the normal (B) variant. These characteristics distinguish this variant from previously reported variants associated with CNSHA and we have called it G6PD Dublin.
Case report
The proband, a 31-year-old male was admitted to hospital for investigation of jaundice. He had had a 'flu-like' illness one week before this. Jaundice had also occurred 3 
Results

G6PD ACTIVITY
Red cell G6PD activity in the proband was less than 10% of normal (6.1 ± 2.7%).
ELECTROPHORESIS
On starch gel the partially purified G6PD from the proband migrated to a similar position to the normal B (100%).
KINETIC CHARACTERISTICS
The Michaelis constant for glucose-6-phosphate of the partially purified enzyme of the proband was within normal limits, 66 Vmol/l. Similarly, the Michaelis constant for NADP was 2-79 ± 0.12 V.mol/l, the normal (B) being 2-9 to .tmol/l.
Utilisation of the substrate analogue 2-deoxyglucose-6-phosphate was, however, consistently markedly increased, 26 ± 2 .0% of that of glucose-6-phosphate as shown in table 1.
pH EFFECT The effect of pH on the enzyme activity of the mutant G6PD was found to be similar to that of the normal B enzyme with a pH optimum at pH 8 0.
STABILITY
Partially purified mutant and control enzymes were heated at various temperatures until a temperature was found which caused a loss of about 20 % of the activity in 20 minutes. Activity loss was too rapid to be followed above 500C in the case of the mutant enzyme. However, at 440C the mutant G6PD was found to be relatively heat stable. The rates of inactivation in the case of the control, diluted control, and mutant enzyme are shown in the figure.
The mutant enzyme was highly unstable in a crude haemolysate and lost its activity within a few hours. On freezing and thawing the haemolysate, loss in activity was almost instantaneous. When mixed with haemolysates from the deficient subject the activity of normal G6PD was not affected. Normal and mutant enzyme, partially purified, remained stable for 3 months when stored at 40C. The red cell 6-phosphogluconate dehydrogenase (6PGADH) activity was within normal limits.
Discussion
It is now established4 that G6PD deficiency is by far the most common enzyme abnormality in man. In two of the major clinical groups, the 'Mediterranean' and 'Negro' types, haemolytic anaemia occurs only when the patient is subjected to an oxidant stress, such as oxidant drugs, infections, or in the case of the 'Mediterranean' type, fava beans. In the socalled 'sporadic' type, a chronic haemolytic state may exist in the absence of any oxidant stress and this is referred to as chronic non-spherocytic haemolytic anaemia (CNSHA).5
In the patient reported above, the activity of G6PD was abnormally low. Further studies showed it to be different from normal G6PD and from other variants previously described. In table 2, the The most distinctive features of the mutant enzyme are its low red cell activity (less than 10% of normal), the relative heat stability, and the marked increased in utilisation of 2 deoxy G6P, when compared with the normal G6PD. Studies of the heat stability of the enzyme at 440C (figure) indicate that the mutant is more stable than normal G6PD. The increased activity with 2 deoxy G6P is very important in distinguishing the mutant from almost all the known variants of G6PD. It 
